ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
27 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
20K
|
6.9M
|
27
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
16 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
20K
|
6.9M
|
16
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
15 |
13/06/22 |
13/06/22 |
ASX - By Stock
|
20K
|
6.9M
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
8 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
20K
|
6.9M
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
23 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
20K
|
6.9M
|
23
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
29 |
30/05/22 |
30/05/22 |
ASX - By Stock
|
20K
|
6.9M
|
29
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Pause in Trading
|
|
Spuderman
|
26 |
7.1K |
6 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
26
|
7.1K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Pause in Trading
|
|
Spuderman
|
26 |
7.1K |
16 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
26
|
7.1K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: CEO & CSO Employment Update
|
|
Spuderman
|
35 |
12K |
36 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
35
|
12K
|
36
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
6 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
20K
|
6.9M
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
12 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
20K
|
6.9M
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
28 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
20K
|
6.9M
|
28
|
|
ASX - By Stock
|
RAC |
Re:
next 2 announcements
|
|
Spuderman
|
9 |
5.0K |
15 |
14/03/22 |
14/03/22 |
ASX - By Stock
|
9
|
5.0K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in Melanoma preclinical study
|
|
Spuderman
|
179 |
60K |
3 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
179
|
60K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Spuderman
|
10K |
3.7M |
7 |
18/01/22 |
18/01/22 |
General
|
10K
|
3.7M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in Melanoma preclinical study
|
|
Spuderman
|
179 |
60K |
4 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
179
|
60K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in Melanoma preclinical study
|
|
Spuderman
|
179 |
60K |
13 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
179
|
60K
|
13
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Spuderman
|
10K |
3.7M |
16 |
13/01/22 |
13/01/22 |
General
|
10K
|
3.7M
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr John Cullity
|
|
Spuderman
|
137 |
41K |
8 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
137
|
41K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr John Cullity
|
|
Spuderman
|
137 |
41K |
9 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
137
|
41K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr John Cullity
|
|
Spuderman
|
137 |
41K |
39 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
137
|
41K
|
39
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
7 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
20K
|
6.9M
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
22 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
20K
|
6.9M
|
22
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
46 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
20K
|
6.9M
|
46
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Spuderman
|
10K |
3.7M |
12 |
07/01/22 |
07/01/22 |
General
|
10K
|
3.7M
|
12
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
13 |
05/01/22 |
05/01/22 |
ASX - By Stock
|
20K
|
6.9M
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race raises $29.7 million in oversubscribed SPP
|
|
Spuderman
|
378 |
99K |
3 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
378
|
99K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Spuderman
|
10K |
3.7M |
24 |
21/12/21 |
21/12/21 |
General
|
10K
|
3.7M
|
24
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Spuderman
|
10K |
3.7M |
7 |
01/12/21 |
01/12/21 |
General
|
10K
|
3.7M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
SPP Survey
|
|
Spuderman
|
314 |
88K |
43 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
314
|
88K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Share Purchase Plan Opens
|
|
Spuderman
|
557 |
156K |
10 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
557
|
156K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Share Purchase Plan Opens
|
|
Spuderman
|
557 |
156K |
61 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
557
|
156K
|
61
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Spuderman
|
10K |
3.7M |
2 |
17/11/21 |
17/11/21 |
General
|
10K
|
3.7M
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Spuderman
|
10K |
3.7M |
1 |
17/11/21 |
17/11/21 |
General
|
10K
|
3.7M
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Spuderman
|
10K |
3.7M |
22 |
14/11/21 |
14/11/21 |
General
|
10K
|
3.7M
|
22
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Spuderman
|
19K |
6.4M |
60 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
19K
|
6.4M
|
60
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Spuderman
|
19K |
6.4M |
16 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
19K
|
6.4M
|
16
|
|
ASX - By Stock
|
IHL |
Re:
General discussion
|
|
Spuderman
|
19K |
6.4M |
5 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
19K
|
6.4M
|
5
|
|
ASX - By Stock
|
IXR |
Re:
IXR Charting & T/A
|
|
Spuderman
|
1.9K |
793K |
18 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
1.9K
|
793K
|
18
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
38 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
20K
|
6.9M
|
38
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
Spuderman
|
3.0K |
1.1M |
6 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
3.0K
|
1.1M
|
6
|
|
ASX - By Stock
|
IHL |
Re:
CHART Thread
|
|
Spuderman
|
3.0K |
1.1M |
11 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
3.0K
|
1.1M
|
11
|
|
ASX - By Stock
|
RNU |
Re:
RNU chart
|
|
Spuderman
|
4.1K |
1.7M |
2 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
4.1K
|
1.7M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
RACE: Marketing Blitz 2021-2022
|
|
Spuderman
|
104 |
35K |
51 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
104
|
35K
|
51
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
11 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
20K
|
6.9M
|
11
|
|
ASX - By Stock
|
RAC |
Re:
RAC Broker Data
|
|
Spuderman
|
154 |
46K |
7 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
154
|
46K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Preclinical & Clinical Programs Update
|
|
Spuderman
|
186 |
56K |
49 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
186
|
56K
|
49
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
24 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
20K
|
6.9M
|
24
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
18 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
20K
|
6.9M
|
18
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Spuderman
|
20K |
6.9M |
46 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
20K
|
6.9M
|
46
|
|